Overview
Valued at ~$4.40 billion in 2023, the hernia mesh market is projected to reach ~$5.64
billion by 2028, increasing at a CAGR of 5.1% over the 2023-2028 forecast period.
This Market Snapshot is part of LSI’s Market
Intelligence platform, your one-stop-shop for global medtech market sizing and analysis, procedure
volume data, startup company- and deal-tracking, curated insights, and more.
A hernia develops when there is a weakness or opening in the connective tissues and muscles of the abdomen. A
surgical mesh is used to close the opening and reinforce the surrounding tissue to repair the hernia.
Products included within the scope of this analysis include:
Biologic hernia mesh
Synthetic hernia mesh
Permanent and resorbable meshes
This Market Snapshot is intended to provide a high-level overview of the global market for hernia repair mesh,
with key insights into:
Unit volumes from 2023 to 2028
Market forecasts from 2023 to 2028
Market insights
Competitive landscape analysis of major competitors
Insights into key market events for strategic and startups
Hernia Mesh Market Snapshot Summary
| Snapshot Aspect | Data and Details |
| Base Year for Estimate | 2023 |
| Forecast Period | 2023 - 2028 |
| Market Size in 2023 | $4.40 billion |
| CAGR | 5.1% |
| Projected Market Size in 2028 | $5.64 billion |
Hernia Mesh Market Insights
Growth in the hernia mesh market is largely driven by the increasing average selling price for hernia repair
mesh, fueled by the introduction of next-generation meshes that command higher prices. Market growth is
forecasted at 5.1% over the 2023-2028 interval—a slight increase from the previous year’s analysis. A key driver
of this growth is the aging global population, with the number of people aged 65 and older expected to grow at a
rate of 2.9% per year over the forecast period, increasing the prevalence of hernias and the demand for repair
solutions.
Recent pricing pressures have hindered market growth as physicians increasingly opt for lower-cost, clinically
suboptimal hernia repair alternatives. Pressure on prices is expected to remain a key factor limiting market
growth, though prices are rising slower than overall inflation in the medical device market. Advanced hernia
repair products entering the market, such as OviTex from TELA Bio, hold promise for improving patient outcomes
and lowering overall costs. The market's continued growth will depend on positive clinical data and the adoption
of next-generation hernia repair products.
Competitive Landscape
The full Market Snapshot includes a robust analysis of the competitive landscape for the hernia mesh market.
This includes estimated market revenue and market share for key players, such as BD, Ethicon/Johnson & Johnson,
and Olympus.
Select Market Events
| Company | Date | Type | Event |
|
Johnson & Johnson
|
12/2023 | Lawsuit | J&J and its subsidiary Ethicon settled over 200 lawsuits regarding its Physiomesh hernia repair. |
|
TELA Bio
|
4/2024 | Product Launch | TELA Bio announced the U.S. commercial launch of its OviTex IHR Reinforced Tissue Matrix. |
Key Companies Covered
BD
Cook Medical
Deep Blue Medical Advances
Ethicon
Exogenesis
Johnson & Johnson
Novus Scientific
Olympus
RTI Biologics
TELA Bio
W.L. Gore
